Research recommendations for cardiovascular aging research

Journal of the American Geriatrics Society

Volumn 44, Issue 9, 1996, Pages 1114-1117

  Premen, Andre J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY RISK; ESTROGEN THERAPY; HEALTH CARE COST; HUMAN; HYPERTENSION; RISK FACTOR; SEX DIFFERENCE;

AGED; AGING; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; GERIATRICS; HEALTH PRIORITIES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH SUPPORT; UNITED STATES;

EID: 0029787221     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb02950.x     Document Type: Review

References (7)

1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women-The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Jama 1995; 273: 199-208.
2. Handbook of Physiology: Section 11: Aging., E.J Masoro, ed. New York: Oxford University Press, 1995. Heart and Stroke Facts. Dallas, TX: American Heart Association, 1994.
3. Heart and Stroke Facts: 1995 Statistical Supplement. American Heart Association, 1994.
4. Hearts and Arteries. What scientists are learning about age and the cardiovascular system. NIH Publication No. 1994:94-3738. Bethesda, MD: National Institute on Aging.
5. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
6. Physical activity and cardiovascular health. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. JAMA 1996; 276: 241-246.
7. US Bureau of the Census. Current Population Reports, Special Studies, P23-190. 65+ in the United States. Washington, DC: US Government Printing Office, 1996.